Y8F-26800-27096
4 vaccinations
6 coded responses
26 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 782 / TX
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Registered in v-safe
-
2021-01-18
Dose 1 — Pfizer-BioNTech
- 2021-01-18
-
2021-01-19
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Site: PainFree text: Muscle soreness at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-02-02
-
2021-02-08
Dose 2 — Pfizer-BioNTech
- 2021-02-08
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Swollen lymph nodes in axillaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Redness · Muscle or body achesFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, RednessFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-12
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, RednessFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-05-10
- 2021-08-09
-
2021-10-29
Dose 3 — Moderna
-
2022-02-09
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Infertility — Feeling: GoodFree text: Infertility and 1 miscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-09-14
Dose 4 — Pfizer-BioNTech
- 2022-12-16
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Pfizer-BioNTech | |
| 2 | 2021-02-08 | Pfizer-BioNTech | |
| 3 | 2021-10-29 | Moderna | No |
| 4 | 2022-09-14 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Muscle soreness at injection site
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes in axilla
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Release 11 — 12 months, dose 2
Symptoms: Infertility and 1 miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Infertility | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release